Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/193208
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ortiz-Maldonado Gibson, Valentín | - |
dc.contributor.author | Rives, Susana | - |
dc.contributor.author | Español Rego, Marta | - |
dc.contributor.author | Alonso Saladrigues, A. | - |
dc.contributor.author | Montoro, Mercedes | - |
dc.contributor.author | Magnano, Laura | - |
dc.contributor.author | Giné Soca, Eva | - |
dc.contributor.author | Pascal i Capdevila, Mariona | - |
dc.contributor.author | Díaz Beyà, Marina | - |
dc.contributor.author | Castella, Maria | - |
dc.contributor.author | Català, Albert | - |
dc.contributor.author | Faura, Anna | - |
dc.contributor.author | Rodríguez Lobato, Luis Gerardo | - |
dc.contributor.author | Oliver Caldés, Aina | - |
dc.contributor.author | Martínez Roca, Alexandra | - |
dc.contributor.author | Rovira, Montserrat | - |
dc.contributor.author | González Navarro, Europa Azucena | - |
dc.contributor.author | Ortega, Juan Ramón | - |
dc.contributor.author | Cid Vidal, Joan | - |
dc.contributor.author | Lozano, Miquel | - |
dc.contributor.author | García Rey, Enric | - |
dc.contributor.author | Fernández, Sara | - |
dc.contributor.author | Castro Rebollo, Pedro | - |
dc.contributor.author | Jordán García, Iolanda | - |
dc.contributor.author | Villamor i Casas, Neus | - |
dc.contributor.author | Aymerich Gregorio, Marta | - |
dc.contributor.author | Torrebadell Burriel, Montserrat | - |
dc.contributor.author | Deyá, Angela | - |
dc.contributor.author | Fernández de Larrea Rodríguez, Carlos José | - |
dc.contributor.author | Benítez-Ribas, Daniel | - |
dc.contributor.author | Trias, Esteve | - |
dc.contributor.author | Varea, Sara | - |
dc.contributor.author | Calvo Rojas, Gonzalo | - |
dc.contributor.author | Esteve, Jordi | - |
dc.contributor.author | Urbano Ispizua, Álvaro | - |
dc.contributor.author | Juan, Manel | - |
dc.contributor.author | Delgado, Julio (Delgado González) | - |
dc.date.accessioned | 2023-02-07T16:45:23Z | - |
dc.date.available | 2023-02-07T16:45:23Z | - |
dc.date.issued | 2021-12-01 | - |
dc.identifier.issn | 2051-1426 | - |
dc.identifier.uri | http://hdl.handle.net/2445/193208 | - |
dc.description.abstract | The prognosis of patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) remains poor, particularly for those relapsing after allogeneic hema-topoietic cell transplantation (alloHCT). Novel agents such as inotuzumab ozogamicin or blinatumomab achieve increased response rates, but these are generally transient unless followed by alloHCT. Chimeric antigen receptors (CAR) targeting CD19 have shown promising results in R/R ALL, and one of these products (tisagenlecleucel) has been approved for the treatment of patients with R/R ALL up to 25 years of age. | - |
dc.format.extent | 4 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | BMJ Publishing Group | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1136/jitc-2021-003644 | - |
dc.relation.ispartof | Journal for ImmunoTherapy of Cancer , 2021, vol. 9, num. 12, p. e003644 | - |
dc.relation.uri | https://doi.org/10.1136/jitc-2021-003644 | - |
dc.rights | cc-by-nc (c) Ortiz-Maldonado, Valentín et al., 2021 | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | - |
dc.source | Articles publicats en revistes (Medicina) | - |
dc.subject.classification | Leucèmia limfocítica crònica | - |
dc.subject.classification | Cèl·lules canceroses | - |
dc.subject.classification | Teràpia cel·lular | - |
dc.subject.classification | Antígens CD | - |
dc.subject.classification | Immunoteràpia | - |
dc.subject.classification | Receptors cel·lulars | - |
dc.subject.other | Chronic lymphocytic leukemia | - |
dc.subject.other | Cancer cells | - |
dc.subject.other | Cellular therapy | - |
dc.subject.other | CD antigens | - |
dc.subject.other | Immunotheraphy | - |
dc.subject.other | Cell receptors | - |
dc.title | Factors associated with the clinical outcome of patients with relapsed/refractory CD19+acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 718809 | - |
dc.date.updated | 2023-02-07T16:45:23Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
718809.pdf | 571.93 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License